SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F
http://www.w3.org/2000/01/rdf-schema#comment
"Heterodimerization of alpha4 integrin with endogenous beta1 integrin (CD29) is confirmed to influence targeting therapy for osteopenic bone defects using mouse mesenchymal stem cells."
xsd:string
http://purl.uniprot.org/uniprot/#_E441D6983490466FD0D92D67FDDAB9E0DA52918D5DDCE733353010B836C5CF73D964A2331EFA9FC1878A05F9F72D85F5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F
http://purl.uniprot.org/uniprot/Q8BQ25
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F
http://purl.uniprot.org/uniprot/#_Q8BQ25-mappedCitation-17622670
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AA6CEAF1D279CBB75106C2FF1F7ADE918CC2AD7A759A9A87FB1353E394395A5F88BE853DB27BD6A755D7B4ECFF0DD59F